New Jersey S 2036: Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.

Status: Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee (as of 2026-01-13)

State: New Jersey · Session: 222 · Bill: S 2036

Sponsors: Polistina, Vincent J., Steinhardt, Douglas J.

View New Jersey S 2036 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.